Quanterix Corp (NAS:QTRX)
$ 12.33 -0.14 (-1.12%) Market Cap: 473.21 Mil Enterprise Value: 215.93 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 70/100

Quanterix Corp at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 12:00AM GMT
Release Date Price: $24.75 (+14.32%)
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

All right. We're going to go ahead and get started. Good afternoon. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce Quanterix. We'll do a breakout right after in the Yorkshire Room. And with that, let me turn it over to Kevin.

E. Kevin Hrusovsky
Quanterix Corporation - Chairman, President & CEO

Thank you very much, Tycho. It's always a pleasure to be here. We've got some exciting news to discuss today, representing Quanterix. Before starting, please consult your regulatory filings before investing in our stock.

Today, I'm going to discuss 2 things around the company: one is we have a pretty incredible story over the last 5 years on the research side, where we're executing, and it's pretty strong execution story. Today, we'll further build upon that because we will give some revenue indication of our Q4 performance. But I also wanted to talk about some aspiration around diagnostics and some of the ways we think we can disrupt moving forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot